Reducing serum cholesterol levels in people having type II diabetes is linked with DPN (diabetic polyneuropathy), as per to a study. The research was published in JAMA Network Open. Johann M.E. Jende—from Heidelberg University Hospital, Germany—along with colleagues assessed the link amid peripheral nerve lesions and serum cholesterol levels in patients having type II diabetes both with and without DPN. Approximately, 100 participants (with average age 64.6 Years and 68% male) underwent MRN (magnetic resonance neurography) of the right leg, plus serologic, clinical, and electrophysiologic evaluation.
The scientists discovered that the LEL (lipid equivalent lesion) load completely correlated with the maximum length of a lesion and the nerves mean cross-sectional area. A negative link was noted amid LEL load and low- and high-density lipoprotein cholesterol level, total serum cholesterol level, nerve conduction velocities/amplitudes of the peroneal and tibial nerves. The authors stated, “These outcomes of study might be appropriate to emerge treatments that encourage an aggressive reduction of serum cholesterol levels in people having type II diabetes.”
On a similar note, recently, a twins study linked to type II diabetes in midlife by stroke and the brain artery narrowing in the later life. A new study showed that type II diabetes in midlife is connected with a 30% surged jeopardy of severe blockage of the brain arteries, mostly causing stroke and a doubling of the peril of contracting of the brain’s arteries in individuals more than 60 Years. The study was based on a group of twins in Sweden and was issued in Diabetologia, which is the journal of the EASD (European Association for the Study of Diabetes). This study aimed to study whether familial and genetic-environmental factors can explain the connection between type II diabetes and CBD.